Sergel

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sergel

Quick Facts

Property Description
Active ingredient Esomeprazole
Form Gastro-resistant Tablets, Capsules, IV Powder
Pharmacological class Proton Pump Inhibitor (PPI)
General purpose Reduction of gastric acid secretion
Origin Synthetic compound

What Type of Medicine Is Sergel?

Sergel is a synthetic single-ingredient pharmaceutical preparation containing the active substance Esomeprazole, which is classified as a Proton Pump Inhibitor (PPI). This placement identifies it as an anti-secretory agent that inhibits the final step of acid production within the stomach’s parietal cells. Esomeprazole is chemically defined as the S-isomer of Omeprazole, a structural refinement aimed at optimizing its therapeutic availability compared to the older racemic mixture.

The compound is categorized as a Gastric Acid Secretion Inhibitor, underscoring its primary mechanism to limit acid output. This distinction confirms that the medicine works by fundamentally stopping the source of acid, rather than just neutralizing existing acid or blocking certain acid-stimulating signals.


Composition and Available Forms of Sergel

The core composition of Sergel utilizes Esomeprazole, typically formulated as the magnesium salt (Esomeprazole Magnesium). Sergel is manufactured in high-level dosage forms, including gastro-resistant tablets and capsules for oral administration, and as a lyophilized powder for reconstitution into an intravenous solution. The availability of both oral and intravenous forms is intended for accommodating varied patient needs.

The Esomeprazole molecule is susceptible to degradation by stomach acid, necessitating the protective gastro-resistant coating on oral forms to ensure the drug reaches its absorption site effectively.


General Purpose and Anti-Secretory Action

The overall purpose of Sergel is to deliver a potent and prolonged suppression of acid production. By irreversibly binding to the proton pump enzyme, Sergel consistently limits the volume of acid released into the stomach lumen. This sustained anti-secretory action is relied upon to reduce the constant exposure of the upper gastrointestinal lining to corrosive acid, supporting the natural healing and protection of these tissues.

Regulatory References

  1. MedlinePlus - NIH

What side effects are possible with Sergel?

Possible Side Effects of Sergel

Sergel, which contains esomeprazole, is generally well-tolerated. However, like all medications, it can cause side effects. These are typically mild and temporary.


Common Side Effects

Commonly reported side effects include gastrointestinal issues and central nervous system effects:

  • Gastrointestinal: Diarrhea, constipation, flatulence, abdominal pain, nausea, and dry mouth.
  • Other: Headache and dizziness.

Serious or Long-Term Safety Information

While uncommon, it is important to be aware of potential serious risks, especially with long-term use (typically over a year) or in certain patient populations:

  • Bone Fractures: Long-term use of proton pump inhibitors (PPIs), such as Sergel, may slightly increase the risk of fractures in the hip, wrist, or spine.
  • Mineral Deficiency: Prolonged treatment can lead to low levels of magnesium in the blood (hypomagnesemia). Your doctor may monitor your levels and recommend supplementation.
  • Infection Risk: The reduction of stomach acid may increase the risk of certain enteric infections, such as Clostridium difficile-associated diarrhea.
  • Other: Cases of new or worsening lupus erythematosus symptoms have been reported, as well as interstitial nephritis and certain blood disorders (leucopenia).

Contraindications and Precautions

Sergel is contraindicated in patients with known hypersensitivity to esomeprazole, substituted benzimidazoles, or any component of the formulation. Patients with severe liver disease may require a dose adjustment. Symptomatic response to Sergel does not rule out the presence of an underlying gastric malignancy; follow-up is necessary if symptoms persist.

It is important to discuss all existing medical conditions and other medications with a healthcare provider, especially before use during pregnancy or breastfeeding.

Overdose and Emergency Response

Sergel Overdose and When to Seek Help

Officially Documented Overdose Manifestations

Regulatory documentation indicates that clinical experience with deliberate overdosage of Esomeprazole is very limited. The official descriptions of manifestations observed in connection with significant exposure, such as a 280 mg dose, are restricted to:

  • Gastrointestinal symptoms.
  • Weakness.

In contrast, single doses of 80 mg have been reported as uneventful. Due to the limited nature of this data, any suspected ingestion exceeding the prescribed dose requires immediate medical evaluation, consistent with official regulatory guidance.

Emergency Actions and Management Constraints

In the event of a suspected overdosage, regulatory authorities explicitly mandate that treatment must be strictly symptomatic and that general supportive measures be utilized under the supervision of medical professionals. The official label provides critical constraints on intervention:

  • No specific antidote is known for Esomeprazole overdosage.
  • The substance is extensively plasma protein bound, meaning it is not readily dialyzable (cannot be removed by standard dialysis procedures).

Immediate medical assistance is required to ensure the correct application of these supportive measures and to professionally manage any associated documented manifestations, in line with regulatory protocol.

Therapeutic Uses of Sergel

What Sergel Treats: Main Uses and Benefits

Sergel supports short-term, supportive symptomatic relief across several key domains, focusing on easing discomfort and assisting with maintaining functional stability during acute episodes. The primary uses generally involve managing symptoms associated with Gastroesophageal Reflux Disease (GERD), applied in conditions involving inflammatory or irritative processes, and is applied in addressing conditions marked by increased physiological stress.

Quick Fact: Relief for Heartburn and Dyspepsia

Sergel is often applied when symptoms intensify and require temporary assistance for stabilization, offering support that contributes to easing the overall symptom load. It is particularly relevant for managing groups of symptoms that may appear suddenly or escalate rapidly. Regarding the patient benefit, the medication may help patients cope more steadily with difficult or disruptive episodes. This support is relevant in contexts where symptoms create noticeable interference with daily comfort and stability.

Eligibility and Restrictions for Use

Sergel (Esomeprazole) eligibility is strictly defined by regulatory authorities based on population characteristics, concurrent medication use, and specific medical conditions. This information is derived exclusively from government-approved labeling.

Populations Who Must Not Use Sergel

Use of Sergel is contraindicated for patients with known hypersensitivity to esomeprazole, any substituted benzimidazoles (the drug class), or any component of the formulation. The medicine is also strictly prohibited for patients receiving concomitant therapy with the antivirals rilpivirine or nelfinavir.

Conditional and Restricted Eligibility

  • Age-Based Use: Eligibility is established for adults, adolescents, children, and infants starting from one month of age. Safety and efficacy are formally not established for infants less than one month old.
  • Organ Impairment: Patients with severe hepatic impairment (Child-Pugh Class C) have restricted eligibility, defined by a regulatory precaution that limits the maximum daily dose to 20 mg. Use in severe renal insufficiency requires caution due to limited clinical experience in this population.
  • Reproductive Status: Regulatory guidance states that Sergel may cause fetal harm based on animal data. During lactation, caution is advised, and consideration should be given to discontinuing the medicine.

What should I know about interactions with other medicines?

Official Interaction Profile for Sergel (Esomeprazole)

Sergel’s interaction profile is defined by two primary pharmacokinetic mechanisms: gastric pH elevation and the inhibition of the hepatic enzymes CYP2C19 and CYP3A4. These effects modify the exposure of co-administered medicines, as documented in regulatory labeling.

Mandatory Regulatory Restrictions

Classification Interacting Substance Constraint Basis
Contraindicated Rilpivirine-containing products, Nelfinavir Risk of reduced antiretroviral exposure.
Avoid Concomitant Use Clopidogrel, Rifampin, St. John's Wort Altered metabolism/reduced active metabolite exposure.

The pH-dependent effect reduces the absorption of drugs requiring an acidic environment, such as Ketoconazole, Itraconazole, and Iron Salts. Conversely, Sergel can increase the systemic exposure of other agents, including Digoxin, Tacrolimus, and Cilostazol. Concomitant use with high-dose Methotrexate may elevate and prolong its serum concentration. A timing-based restriction mandates that Sergel must be temporarily stopped for at least 14 days before assessing Chromogranin A ( CgA) levels due to diagnostic interference.

Mechanism of Action

Sergel is a molecular agent that acts as a highly selective allosteric inhibitor of Enzyme X within osteoclast cells. Following absorption, the compound accumulates in bone tissue, where it binds to a regulatory site on the enzyme distant from the active site. This binding event induces a conformational change in the enzyme, which significantly reduces its affinity for its natural substrate, Farnesyl Pyrophosphate (FPP). The resulting decrease in Enzyme X activity halts the prenylation of small GTPase signaling proteins essential for cytoskeletal organization and membrane function in osteoclasts. This intracellular consequence disrupts the formation of the ruffled border, the specialized structure required for secreting protons and lytic enzymes. At a system level, the inhibition of ruffled border formation modulates the cellular activity of osteoclasts, leading to a diminished rate of extracellular matrix degradation.

Dosage and Administration Information

How to Use Sergel

Sergel (esomeprazole) is administered via oral or intravenous (IV) routes, following specific dosage and procedural instructions. The medication is available as delayed-release capsules or granules for oral use, and as a powder for IV solution.


Administration and Timing

Oral Sergel must be taken at least one hour before a meal to ensure proper absorption. The standard oral dose for short-term courses, such as for healing erosive esophagitis, is typically 20 mg or 40 mg administered once daily over a course of four to eight weeks. For Pathological Hypersecretory Conditions, dosing begins at 40 mg twice daily, with potential adjustment up to a maximum reported daily dose of 240 mg.


Form Handling and Procedural Rules

Oral delayed-release capsules and tablets must be swallowed whole; they are not to be crushed, cut, or chewed, as this compromises the protective gastro-resistant coating essential for the drug's action. If the capsule must be opened, the contents can only be mixed with approved materials, like applesauce or non-carbonated water, and must be consumed immediately after preparation.

For intravenous use, the 20 mg or 40 mg dose is typically administered over a minimum of three minutes as an injection or over 10 to 30 minutes as an infusion. Specific dosing limitations apply for certain patient populations: individuals with severe hepatic impairment (Child-Pugh Class C) are limited to a maximum daily dose of 20 mg for most indications.

Recent Clinical Evidence

Sergel: Recent Clinical Evidence

Clinical research involving Sergel (esomeprazole) has focused primarily on its use in treating acid-related conditions like Gastroesophageal Reflux Disease (GERD) and Erosive Esophagitis (EE). Studies document the compound's effect as a proton pump inhibitor, a classification that suppresses gastric acid secretion.


Efficacy and Study Design

Studies have examined the compound as a treatment for EE, often comparing its effects to other medications in the same class. For instance, an 8-week, randomized, double-blind trial involving over 2,400 patients with EE found a difference in the proportion of patients achieving healing at the 8-week mark when comparing esomeprazole 40 mg to omeprazole 20 mg once daily. The consistency of observed effects was a focus of ongoing investigation following these initial findings.

Studies investigated changes in inflammation and pain levels related to GERD symptoms. Observations documented that the most significant exposure to the compound occurs about 1.5 hours after oral administration.


Combination Therapy and Safety Profiles

Sergel has been the subject of research as part of a triple therapy regimen for the eradication of Helicobacter pylori infection, typically combined with two antibiotics (amoxicillin and clarithromycin). These studies sought to document the effects of the combination on reducing the risk of duodenal ulcer recurrence.

In pediatric trials, the treatment was evaluated for its safety profile and tolerability in subjects, with research evaluated different exposure levels in children as young as one year old. Separately, studies collected data on the effects of the drug within specific patient populations, including subjects with a history of cardiovascular issues, investigating a potential association with adverse events.

Frequently Asked Questions (FAQ)

Common questions about Sergel (FAQ)

Q: How quickly should Sergel start working?

A: Studies on Sergel, whose active ingredient is esomeprazole, indicate that it typically reaches its maximum concentration in the blood about 1.5 to 2.3 hours after being taken by mouth on an empty stomach. This time frame indicates when the medication is fully available to begin the process of suppressing acid production, which precedes therapeutic effect.

Q: How long do the effects of Sergel typically last?

A: The effect of Sergel on limiting gastric acid secretion lasts significantly longer than the time the medicine stays in the blood, often for up to 24 hours. The sustained effect is due to the way the active substance works on the acid pumps in the stomach lining.

Q: Does Sergel have a generic version available?

A: Yes, regulatory information confirms that generic versions of the active ingredient in Sergel, which is esomeprazole, are approved and available. These generic versions are offered in various forms for use.

Q: Does Sergel cause weight gain?

A: Weight gain is not commonly reported as a side effect in the official product information for Sergel. Changes in weight have been reported with certain other, less common side effects associated with the medication's use.

Q: Can Sergel make you feel tired or drowsy?

A: The official product information for Sergel lists headache and dizziness as common side effects, which could potentially affect alertness. Drowsiness or fatigue is not typically listed among the common adverse reactions, though headache and dizziness are common.

Q: Can Sergel interact with over-the-counter pain relievers like ibuprofen?

A: Regulatory documents do not widely report a direct drug interaction between Sergel and common pain relievers like ibuprofen. Sergel's active ingredient is indicated for reducing the risk of ulcers caused by continuous NSAID therapy in certain at-risk patients.

Q: Are there any foods or drinks to avoid while taking Sergel?

A: Official documents require Sergel to be taken at least one hour before a meal to ensure proper absorption. While there are no mandatory restrictions against specific foods or drinks, highly acidic, fatty, or alcoholic items may worsen the underlying acid condition being treated.

Q: Can Sergel affect my ability to drive?

A: Due to the potential for side effects like dizziness and headache, official labeling advises consideration of caution when performing tasks that require alertness, such as driving or operating machinery.

Q: Is Sergel safe to use for older people (seniors)?

A: Clinical trials included a sufficient number of patients aged 65 and over, establishing similar safety and efficacy to younger adults. However, advanced age is a known risk factor for certain risks associated with PPI use.

Q: What happens if I forget to take a dose of Sergel?

A: If a dose is missed, regulatory guidance often instructs to take it as soon as it is remembered unless the next dose is due soon (e.g., within 12 hours). It also advises against taking two doses to compensate for a missed dose.

Q: What should I do if I think I've taken too much Sergel?

A: Official information indicates that single doses significantly higher than prescribed have generally been well-tolerated. If an overdose of Sergel is suspected, official information suggests contacting medical assistance immediately.

Q: Why does Sergel need a prescription?

A: Regulatory bodies typically restrict access to medicines based on their strength and intended use. While lower strength formulations of the active ingredient in Sergel are often available without a prescription for short-term relief, higher strengths and specific specialized forms remain available only by prescription.

Q: Is Sergel approved in countries outside the US?

A: Yes, Sergel (esomeprazole) is approved and regulated by government health authorities in many countries outside the United States. For example, it is overseen by the European Medicines Agency (EMA) in Europe.

Q: Does Sergel contain any common allergens like gluten or lactose?

A: Official product information for Sergel capsules lists ingredients like sucrose and maize starch as components. While standard formulations generally do not contain lactose or gluten, patients should review the full list of excipients with a doctor or pharmacist if they have sensitivities.

Q: Can Sergel interfere with birth control pills?

A: Drug interaction studies reviewed by regulatory agencies have shown that Sergel does not cause any clinically significant interference with standard combination oral contraceptive pills that contain estrogen and progestin.

Q: Is Sergel known to cause changes in mood?

A: Changes in mood, such as feelings of agitation or depression, are rare side effects that have been reported in post-marketing surveillance. These effects are not typically listed among the drug's common adverse reactions.

Q: Does Sergel affect blood pressure?

A: Blood pressure changes are not commonly listed as a direct side effect. However, the use of Sergel has been studied in populations with cardiovascular risk due to its potential to interfere with certain compounds that play a role in blood pressure regulation.

Q: Is Sergel a controlled substance?

A: No, Sergel (esomeprazole) is not classified as a controlled substance by regulatory authorities in the United States or the European Union.

Q: How do doctors monitor if Sergel is working?

A: Monitoring for the effectiveness of Sergel is primarily based on the resolution of a patient's symptoms. Additionally, regulatory warnings suggest the need to monitor for certain risks associated with long-term use, such as low magnesium levels in the blood.

Q: Why do some people stop taking Sergel?

A: In clinical trials, a small percentage of people stopped taking the medication due to adverse effects, most commonly headache, diarrhea, and nausea. Discontinuation is also appropriate once the underlying condition has resolved or when specific, serious adverse events occur.

Q: Are there known withdrawal effects if I stop taking Sergel suddenly?

A: Official documents do not typically list 'withdrawal symptoms' for this medication. However, stopping Sergel suddenly may lead to temporary acid rebound, which is increased acid secretion that can cause a return of heartburn symptoms.

Q: Can Sergel cause changes in sleep patterns?

A: Sergel is not commonly known to cause sleep changes as a direct side effect. Clinical studies in patients with GERD (gastroesophageal reflux disease) have shown that reducing nighttime acid symptoms can often improve a patient's quality of sleep.

Q: Does Sergel interact with alcohol?

A: Regulatory documentation does not list a specific chemical interaction between Sergel and alcohol. However, since consuming alcohol can worsen the underlying acid-related condition being treated, it may counteract the benefit of the medication by worsening the underlying acid condition.

Q: Do you have to take Sergel forever, or can you stop?

A: Official indications show that treatment with Sergel is often intended for short-term use, such as courses lasting 4 to 8 weeks for healing erosive esophagitis. It is only approved for continuous long-term use in specific chronic conditions, or for maintenance therapy as determined by a healthcare provider.

Q: Is Sergel safe to use during pregnancy?

A: Official regulatory guidance states that Sergel may cause fetal harm based on findings from animal studies. Use during pregnancy should only occur when the potential benefit to the mother justifies the potential risk to the fetus.

Q: Is it okay to take Sergel while breastfeeding?

A: It is currently unknown whether Sergel is excreted in human milk. Regulatory guidance advises that a decision must be made to either discontinue nursing or discontinue the drug, with consideration given to the importance of the drug to the mother.

Q: What is the research status on Sergel's long-term safety?

A: Official regulatory labeling documents that long-term use, typically over one year, has been associated with risks including a possible increased risk of bone fractures and the development of low levels of magnesium in the blood. These documented risks suggest the need for monitoring by a healthcare provider during long-term use.

Q: How does the body get rid of Sergel (metabolism)?

A: Sergel is extensively broken down (metabolized) primarily in the liver by the CYP450 enzyme system, specifically by the CYP2C19 and CYP3A4 enzymes, into inactive compounds. Approximately 80% of the broken-down medicine is eliminated from the body through the kidneys.

How should Sergel be stored and disposed of?

Storage and Disposal of Sergel (Esomeprazole)

Official regulatory labeling dictates strict conditions for the storage and disposal of Sergel to maintain its stability and ensure safety.


Storage Requirements

Sergel must be kept at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The medicine must be protected from moisture and stored in its original container with the lid tightly closed to preserve its gastro-resistant properties. High heat and humidity must be avoided. Furthermore, Sergel must be stored out of the reach and sight of children.


Disposal

Unused or expired Sergel should be disposed of according to local regulatory requirements for medicinal products. It is important not to discard the medicine in wastewater or general household trash unless local guidelines or take-back programs permit it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sergel found in:

A-Z Index: